オメガ3 - 世界市場の考察、競合情勢、市場予測（2030年）

世界のオメガ3の市場規模は、2024年～2030年の予測期間にCAGRで7.28%の成長が推定されています。市場は、脳卒中などの心臓疾患の有病率の増加、世界のうつ病患者の増加、スポーツ栄養におけるオメガ3サプリメントの使用の増加、美容目的でのオメガ3サプリメントの使用の増加、世界中での高品質で豊富なオメガ3製品の提供における進歩によって楽観的な市場成長を示しており、さらに予測期間（2024年～2030年）に市場の大きな収益成長につながると予測されています。

オメガ3の市場力学

オメガ3市場の主な成長要因の1つは、世界中での脳卒中やうつ病を患う人々の増加です。World Stroke Organizationのレポート、Global Stroke Fact Sheet（2023）によると、脳卒中は毎年平均1,220万件発生しており、そのうち62%は70歳以下で発生しています。さらに、同資料によると、高い収縮期血圧、高い肥満度、高い空腹時血糖値、高い総コレステロール、低い糸球体ろ過率などのリスクが、2019年の世界の脳卒中リスクの71.0％を占めています。内部の炎症によってもたらされる血管の損傷は、心臓病や脳卒中を引き起こす可能性があります。オメガ3脂肪酸は、中性脂肪値や血圧を下げ、また血栓を予防することで、心臓に恩恵をもたらす可能性があります。

うつ病もまた、予測期間におけるオメガ3市場の主な促進要因の1つです。世界保健機関（WHO）のデータ（2023）によると、2019年に約2億8,000万人がうつ病を患っています。うつ病は、特に再発性で中等度から重度の場合、深刻な病状に発展する可能性があります。罹患者は深刻な苦しみを経験し、仕事や学校、家庭でのパフォーマンスが低下する可能性があります。オメガ3は脳細胞膜を容易に通過し、気分に影響する分子と相互作用します。さらに、抗炎症作用もあり、うつ病を軽減する可能性があります。統合失調症、境界性パーソナリティ障害、強迫性障害、注意欠陥障害などの精神疾患も、オメガ3が治療や予防につながる可能性が指摘されています。上記のような要因から、脳卒中とうつ病の有病率の増加は、予測期間にオメガ3の需要を増加させることが見込まれます。

脳卒中やうつ病の有病率の上昇に加え、主要市場企業によって新しいオメガ3製品が発売されており、このこともオメガ3の需要を促進しています。例えば、2022年7月、植物性の持続可能なブランドに焦点を当てた、多様で完全に統合されたヘルス・ウェルネス組織であるNeptune Wellness Solutions Inc.は、人体の栄養要件の達成に向けた、アヒフラワーを主成分とする新しいForest Remediesの植物性Multi Omega 3-6-9グミおよびソフトジェルを発売しました。

したがって、2024年～2030年の予測期間に、上記の要因の相互作用が総合的にオメガ3市場全体を牽引します。

しかし、血液凝固に影響する薬剤との相互作用のリスクや、前立腺がんのリスク、口臭、悪臭の汗、吐き気、頭痛などの軽度の影響などの特定の副作用が、オメガ3市場の成長抑制要因として作用する可能性があります。

オメガ3市場は、COVID-19パンデミック中に一般市民への感染拡大のリスクを回避するために厳格なロックダウンが課されたため、軽度の影響を受けました。オメガ3市場は、パンデミック期に健康と免疫力を高める必要性が認識され、需要が大幅に増加しました。しかしその一方で、大規模な産業や製造施設の一時閉鎖により、オメガ3の高い需要を満たすことができませんでした。さらに、オンラインポータルが機能している地域もあれば、配達ができない地域もあり、オンラインサイトでの販売も不可能でした。しかし、大衆が予防接種を受け、食品や医療部門の活動が再開され、ロックダウンも解かれたことで、オメガ3の市場全体が平常に戻り、病院、診療所、研究所での治療や診断に向けた定期的な外来受診といった医療サービスが再開され、オメガ3市場の製品需要が軌道に乗っています。

当レポートでは、世界のオメガ3市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 オメガ3市場レポートのイントロダクション

第2章 オメガ3市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

第4章 オメガ3市場の主な要因の分析

• オメガ3市場の促進要因
• オメガ3市場の抑制要因と課題
• オメガ3市場の機会

第5章 オメガ3市場のポーターのファイブフォース分析

第6章 オメガ3市場に対するCOVID-19の影響分析

第7章 オメガ3市場のレイアウト

• 原料別
  • 海洋原料
  • 植物原料
• 組成別
  • α-リノレン酸（ALA）
  • エイコサペンタエン酸（EPA）
  • ドコサヘキサエン酸（DHA）
• 用途別
  • 栄養補助食品
  • 機能性食品、飲料
  • 医薬品
  • その他
• 地域
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 オメガ3市場の企業と製品のプロファイル

• Aker Biomarine Antarctic AS
• Orkla Health
• BASF Corporation
• Omega Protein Corporation
• GC Reiber Oils
• Lonza
• Croda International Plc
• EPAX
• BioProcess Algae, LLC
• DSM
• Evonik
• Cargill Incorporated
• Golden Omega
• Corbion
• Polaris
• Olvea Fish Oils
• Pharma Marine AS
• Clover Corporation
• Solutex
• Stepan Company

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項、お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Omega 3 Market
• Table 3: Omega 3 Market Analysis in Global (2021-2030)
• Table 4: Omega 3 Market Analysis in Global by Source (2021-2030)
• Table 5: Omega 3 Market Analysis in Global by Composition (2021-2030)
• Table 6: Omega 3 Market Analysis in Global by Application (2021-2030)
• Table 7: Omega 3 Market Analysis in Global by Geography (2021-2030)
• Table 8: Omega 3 Market Analysis in North America (2021-2030)
• Table 9: Omega 3 Market Analysis in North America by Country (2021-2030)
• Table 10: Omega 3 Market Analysis in the US (2021-2030)
• Table 11: Omega 3 Market Analysis in Canada (2021-2030)
• Table 12: Omega 3 Market Analysis in Mexico (2021-2030)
• Table 13: Omega 3 Market Analysis in Europe (2021-2030)
• Table 14: Omega 3 Market Analysis in Europe by Country (2021-2030)
• Table 15: Omega 3 Market Analysis in France (2021-2030)
• Table 16: Omega 3 Market Analysis in Germany (2021-2030)
• Table 17: Omega 3 Market Analysis in the UK (2021-2030)
• Table 18: Omega 3 Market Analysis in Italy (2021-2030)
• Table 19: Omega 3 Market Analysis in Spain (2021-2030)
• Table 20: Omega 3 Market Analysis in the Rest of Europe (2021-2030)
• Table 21: Omega 3 Market Analysis in Asia-Pacific (2021-2030)
• Table 22: Omega 3 Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 23: Omega 3 Market Analysis in China (2021-2030)
• Table 24: Omega 3 Market Analysis in Japan (2021-2030)
• Table 25: Omega 3 Market Analysis in India (2021-2030)
• Table 26: Omega 3 Market Analysis in Australia (2021-2030)
• Table 27: Omega 3 Market Analysis in South Korea (2021-2030)
• Table 28: Omega 3 Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Table 29: Omega 3 Market Analysis in the Rest of the World (2021-2030)
• Table 30: Omega 3 Market Analysis in the Rest of the World by Region (2021-2030)
• Table 31: Omega 3 Market Analysis in the Middle East (2021-2030)
• Table 32: Omega 3 Market Analysis in Africa (2021-2030)
• Table 33: Omega 3 Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Omega 3 Market
• Figure 3: Omega 3 Market Analysis in Global (2021-2030)
• Figure 4: Omega 3 Market Analysis in Global by Source (2021-2030)
• Figure 5: Omega 3 Market Analysis in Global by Composition (2021-2030)
• Figure 6: Omega 3 Market Analysis in Global by Application (2021-2030)
• Figure 7: Omega 3 Market Analysis in Global by Geography (2021-2030)
• Figure 8: Omega 3 Market Analysis in North America (2021-2030)
• Figure 9: Omega 3 Market Analysis in North America by Country (2021-2030)
• Figure 10: Omega 3 Market Analysis in the US (2021-2030)
• Figure 11: Omega 3 Market Analysis in Canada (2021-2030)
• Figure 12: Omega 3 Market Analysis in Mexico (2021-2030)
• Figure 13: Omega 3 Market Analysis in Europe (2021-2030)
• Figure 14: Omega 3 Market Analysis in Europe by Country (2021-2030)
• Figure 15: Omega 3 Market Analysis in France (2021-2030)
• Figure 16: Omega 3 Market Analysis in Germany (2021-2030)
• Figure 17: Omega 3 Market Analysis in the UK (2021-2030)
• Figure 18: Omega 3 Market Analysis in Italy (2021-2030)
• Figure 19: Omega 3 Market Analysis in Spain (2021-2030)
• Figure 20: Omega 3 Market Analysis in the Rest of Europe (2021-2030)
• Figure 21: Omega 3 Market Analysis in Asia-Pacific (2021-2030)
• Figure 22: Omega 3 Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 23: Omega 3 Market Analysis in China (2021-2030)
• Figure 24: Omega 3 Market Analysis in Japan (2021-2030)
• Figure 25: Omega 3 Market Analysis in India (2021-2030)
• Figure 26: Omega 3 Market Analysis in Australia (2021-2030)
• Figure 27: Omega 3 Market Analysis in South Korea (2021-2030)
• Figure 28: Omega 3 Market Analysis in the Rest of Asia-Pacific (2021-2030)
• Figure 29: Omega 3 Market Analysis in the Rest of the World (2021-2030)
• Figure 30: Omega 3 Market Analysis in the Rest of the World by Region (2021-2030)
• Figure 31: Omega 3 Market Analysis in the Middle East (2021-2030)
• Figure 32: Omega 3 Market Analysis in Africa (2021-2030)
• Figure 33: Omega 3 Market Analysis in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Market Opportunities
• Figure 37: PORTER's Five Force Analysis

Omega 3 Market By Source (Marine Source And Plant Source), By Composition (Alpha-Linolenic Acid (ALA), Eicosapentaenoic Acid (EPA) And Docosahexaenoic Acid (DHA)) By Application (Dietary Supplements, Functional Food & Beverages, Pharmaceuticals, And Others), and by geography is expected to advance at a respectable cagr forecast till 2030 owing to rise in the prevalence of heart diseases, the growing incidence of depression among population, their increasing use for aesthetic purposes, and the growing advancements in delivering quality and rich omega 3 products across the globe.

The global Omega 3 Market is estimated to grow at a CAGR of 7.28% during the forecast period from 2024 to 2030. The Omega 3 market is observing an optimistic market growth due to increase in the prevalence of heart diseases such as stroke, the increasing cases of people suffering from depression globally, the rising use of omega 3 supplements in sports nutrition, the growing use of omega-3 supplements for aesthetic purposes, and the growing advancements in delivering quality and rich omega 3 products across the globe is further expected to result in appreciable revenue growth of the Omega 3 market during the forecast period (2024-2030).

Omega 3 Market Dynamics:

One of the main factors for the growth of the Omega 3 market is the increasing prevalence of people suffering from stroke and depression globally. As per the reports from World Stroke Organization: Global Stroke Fact Sheet (2023), 12.2 million cases of strokes happen each year on average, where 62% of the total strokes occurring take place in people below 70 years of age. Further, according to the same source, risks such as high systolic blood pressure, high body-mass index, high fasting plasma glucose, high total cholesterol, and low glomerular filtration rate account for 71.0% of the global stroke risk in the year 2019. Blood vessel damage brought on by internal inflammation can result in heart disease and strokes. The heart may benefit from omega-3 fatty acids by lowering triglyceride levels, and blood pressure and also by preventing blood clots.

Depression is also one of the major factors driving the omega-3 market during the given forecast period. According to the World Health Organization data (2023), around 280 million people were living with depression in the year 2019. Depression may develop into a serious medical condition, especially if it is recurrent and of moderate to severe intensity. The affected person may experience severe suffering and perform poorly at work, in school, and in the family. Omega-3 can easily cross the brain cell membrane and interact with molecules that affect mood. Additionally, they have anti-inflammatory properties that could lessen depression. Other psychiatric disorders like schizophrenia, borderline personality disorder, obsessive-compulsive disorder, and attention deficit disorder have also been linked to omega-3s as a potential treatment or preventative measure. Owing to all the above-stated factors, the rise in the prevalence of stroke and depression is expected to increase the demand for Omega 3 during the forecast period.

In addition to the rise in the prevalence of stroke and depression, new Omega 3 products are being launched by key market players, which is also driving the demand for Omega 3. For instance, in July 2022, Neptune Wellness Solutions Inc., a diversified and fully integrated health and wellness organization focused on plant-based and sustainable brands, launched the new Forest Remedies plant-based Multi Omega 3-6-9 gummies and soft gels with Ahiflower as a major ingredient, for fulfilling the nutrient requirement of the human body.

Therefore, the interplay of the factors stated above collectively will drive the overall Omega 3 market during the forecast period from 2024-2030.

However, certain side effects such as risks of interaction with drugs that affect blood clotting, risks of prostate cancer, and other mild effects such as bad breath, bad smelling sweat, nausea, headache, and others may act as restraints for the Omega 3 market growth.

The Omega 3 market was mildly impacted during the COVID-19 pandemic owing to the imposition of strict lockdowns to avoid the risk of the spread of the disease among the general public. The Omega-3 market experienced a substantial rise in its demand owing to the rising awareness and need for building up health and immunity during the pandemic phase. But on the other hand, due to the temporary closure of large-scale industries and manufacturing units, the raised demand for omega-3 could not be met. Furthermore, as the online portals were functional in some places, some regions observed no delivery, due to which sales through online websites were also not possible. However, with the masses being vaccinated, resumption of activities in the food and healthcare sector along with the opening of lockdowns, the overall market for Omega 3 has returned to normalcy leading to the resumption of healthcare services such as regular out-patient visits for treatment and diagnosis in hospitals, clinics, and laboratories, thereby bringing the demand for products on track in the Omega 3 market.

Omega 3 Market Segment Analysis:

Omega 3 Market by source (marine source and plant source), composition (alpha-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid), application (dietary supplements, functional food & beverages, pharmaceuticals, and others), and geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the source segment of the Omega 3 market, the marine segment is expected to have a significant revenue share in the year 2023. This is primarily due to the large bio-availability and the presence of high-quality omega-3 fatty acids from marine sources in the Omega-3 market.

Water bodies such as oceans, support the life of all the organisms living in water, providing them the habitat and adequate sources of nutrition for their mechanism. Due to the large bio-availability of marine life forms in the ocean ecosystem, the extraction of resources and dietary needs from them, becomes relatively easy, as they are present in large numbers. In the case of the sourcing of omega 3, fishes serve as the primary source, due to their high omega 3 fatty acid content and also the presence of other nutrients derived from fish as well. High omega-3 choices include salmon, tuna, mackerel, and pollock. Smaller-bodied forage fish species are also a high source of EPA and DHA. This category includes sardines, anchovies, herring, mackerel, capelin, and hoki.

Thus, considering the growing demand and large bioavailability of Omega 3 sourced from marine sources, various new products are being launched in the market by key players in the Omega 3 market. For example, in January 2020, Wiley Companies launched AlaskOmega, a line of omega-3 and omega-7 concentrates from natural fish oils and is the newest addition to its omega-3 concentrate line. It delivers 200 mg/g of EPA and DHA has been formulated to lack a fishy taste or smell. AlaskOmega omega-3 powder allows formulators to incorporate high levels of omega-3 into a variety of applications and formulations such as meal replacement and sports drink powders, energy bars, baked goods, vitamin blends, dairy products, and other functional foods and beverages.

Therefore, owing to the various advantages associated with Omega 3 sourced from the marine ecosystem, along with the increasing product development activities in the market, this category is expected to witness considerable growth eventually contributing to the overall growth of the global Omega 3 market during the forecast period.

North America is expected to dominate the overall Omega 3 Market:

Among all the regions, North America is expected to dominate the global Omega 3 market in the year 2023 and is expected to do the same during the forecast period from 2024-2030. This can be ascribed to the rising cases of cardiovascular disorders such as coronary artery disease and stroke, the growing prevalence of depression among the population, and others, product development activities such as recent launches in the omega 3 market will increase their demand in the North America region during the given forecast period.

As per data provided by the Centers for Disease Control and Prevention (CDC) (2023), about 20.1 million adults aged 20 and above had CAD in the year 2020. The source further stated that every year, more than 795,000 people in the United States experience stroke, on average.

According to the National Institute of Mental Health (2023), an estimated 21.0 million adults in the United States had at least one major depressive episode, representing 8.4% of the total U.S. adult population. The prevalence of adults with a major depressive episode was highest among individuals aged 18-25, accounting for 17% of the population.

In March 2022, Neptune Wellness Solutions Inc., an integrated health and wellness company focused on plant-based, sustainable, and purpose-driven lifestyle brands announced the launch of Forest Remedies Multi Omega 3-6-9, a line of innovative supplements made with Ahiflower oil, in Sprouts Farmers Market stores in the United States. Such new product launches happening in big markets such as North America, reflect the significance that Omega 3 has in the lifestyle of people in North America.

Thus, the interplay of all the above-mentioned factors will further drive the demand for Omega 3 in North America, thus showing a positive outlook for the North America Omega 3 market during the forecast period.

Omega 3 Market Key Players:

Some of the key market players operating in the Omega 3 Market include Aker Biomarine Antarctic AS, Orkla Health, BASF Corporation, Omega Protein Corporation, GC Reiber Oils, Lonza, Croda International Plc, EPAX, BioProcess Algae, LLC, DSM, Evonik, Cargill Incorporated, Golden Omega, Corbion, Polaris, Olvea Fish Oils, Pharma Marine AS, Clover Corporation, Solutex, Stepan Company, and others.

Recent Developmental Activities in the Omega 3 Market:

In October 2022, Algarithm and Natures Crops International collaborated to launch two brand new omega oil blends for the supplement, food & beverage ingredient usage, Ahiflower 80DHAand 150DHA, a vegan option offering a complete profile of omega3-6-9 solution.

In February 2022, Spanish-based pharmaceutical company Noventure launched EPA3G, a drinkable omega-3 oil sachet comprising 3g of drinkable EPA (eicosapentaenoic acid); after signing an agreement with Azur Global Nutrition.

In December 2020, OZiva, an Indian plant-based nutrition brand, announced the launch of India's first plant-based omega 3 multivitamin supplement Omega Multi, providing 200 mg of vegan EPA and DHA, 100 mg of extra virgin olive oil, along with plant-based vitamins such as vitamin A, D3, E & K2 MK-7.

Key Takeaways from the Omega 3 Market Report Study

• Market size analysis for current Omega 3 Market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Omega 3 market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global Omega 3 market.
• Various opportunities available for the other competitor in the Omega 3 Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current Omega 3 Market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Omega 3 Market growth in the coming future?

Target Audience who can be benefited from this Omega 3 Market Report Study

• Omega 3 products providers
• Research and development organizations
• Omega 3-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Omega 3
• Various end users who want to know more about the Omega 3 Market and latest innovations in the Omega 3 market.

Frequently Asked Questions for the Omega 3 Market:

1. What is Omega 3?

Omega-3 fatty acids are polyunsaturated fatty acids that perform various functions in the body such as lowering triglycerides, reducing inflammation, and supporting heart health, among others. The three main types of omega-3 fatty acids are alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).

2. What is the global market for Omega 3?

The global Omega 3 Market is estimated to grow at a CAGR of 7.28% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Omega 3 market?

The Omega 3 market is witnessing positive growth due to an increase in the prevalence of heart diseases such as stroke, the increasing cases of people suffering from depression globally, the rising use of omega-3 supplements in sports nutrition, the growing use of omega-3 supplements for aesthetic purposes, and the growing advancements in delivering quality and rich omega 3 products across the globe is further expected to result in appreciable revenue growth of the Omega 3 market during the forecast period (2024-2030).

4. Who are the key players operating in the global Omega 3 market?

Some of the key market players operating in the Omega 3 Market include Aker Biomarine Antarctic AS, Orkla Health, BASF Corporation, Omega Protein Corporation, GC Reiber Oils, Lonza, Croda International Plc, EPAX, BioProcess Algae, LLC, DSM, Evonik, Cargill Incorporated, Golden Omega, Corbion, Polaris, Olvea Fish Oils, Pharma Marine AS, Clover Corporation, Solutex, Stepan Company, and others.

5. Which region has the highest share in the Omega 3 market?

Among all the regions, North America is estimated to amass a significant revenue share in the global Omega 3 market. This can be ascribed to the rising cases of cardiovascular disorders such as coronary artery disease and stroke, the growing prevalence of depression among the population, and others, product development activities such as recent launches in the omega 3 market will increase their demand in the North America region during the given forecast period.

Table of Contents

1. Omega 3 Market Report Introduction

2. Omega 3 Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

4. Omega 3 Market Key Factors Analysis

• 4.1. Omega 3 Market Drivers
  • 4.1.1. The rise in the prevalence of heart diseases, and depression among the population
  • 4.1.2. The growing use of omega 3 for aesthetic purposes
  • 4.1.3. Product advancements in delivering quality and rich omega-3 fatty acids.
• 4.2. Omega 3 Market Restraints and Challenges
  • 4.2.1. Risks associated with the interaction of omega 3 with blood clotting factors
  • 4.2.2. Side effects associated with the intake of omega 3
• 4.3. Omega 3 Market Opportunities
  • 4.3.1. The rising trend and passion for following a healthy lifestyle worldwide.
  • 4.3.2. Increasing research and development activities in the food industry.

5. Omega 3 Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Omega 3 Market

7. Omega 3 Market Layout

• 7.1. By Source
  • 7.1.1. Marine Source
  • 7.1.2. Plant Source
• 7.2. By Composition
  • 7.2.1. Alpha-Linolenic Acid (ALA)
  • 7.2.2. Eicosapentaenoic Acid (EPA)
  • 7.2.3. Docosahexaenoic Acid (DHA)
• 7.3. By Application
  • 7.3.1. Dietary Supplements
  • 7.3.2. Functional Food and Beverages
  • 7.3.3. Pharmaceuticals
  • 7.3.4. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Omega 3 Market in USD million (2021-2030)
    • 7.4.1.2. Canada Omega 3 Market in USD million (2021-2030)
    • 7.4.1.3. Mexico Omega 3 Market in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Omega 3 Market in USD million (2021-2030)
    • 7.4.2.2. Germany Omega 3 Market in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Omega 3 Market in USD million (2021-2030)
    • 7.4.2.4. Italy Omega 3 Market in USD million (2021-2030)
    • 7.4.2.5. Spain Omega 3 Market in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Omega 3 Market in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Omega 3 Market in USD million (2021-2030)
    • 7.4.3.2. Japan Omega 3 Market in USD million (2021-2030)
    • 7.4.3.3. India Omega 3 Market in USD million (2021-2030)
    • 7.4.3.4. Australia Omega 3 Market in USD million (2021-2030)
    • 7.4.3.5. South Korea Omega 3 Market in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Omega 3 Market in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Omega 3 Market in USD million (2021-2030)
    • 7.4.4.2. Africa Omega 3 Market in USD million (2021-2030)
    • 7.4.4.3. South America Omega 3 Market in USD million (2021-2030)

8. Omega 3 Market Company and Product Profiles

• 8.1. Aker Biomarine Antarctic AS
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Orkla Health
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. BASF Corporation
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Omega Protein Corporation
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. GC Reiber Oils
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Lonza
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Croda International Plc
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. EPAX
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. BioProcess Algae, LLC
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. DSM
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Evonik
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Cargill Incorporated
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Golden Omega
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Corbion
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Polaris
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy
• 8.16. Olvea Fish Oils
  • 8.16.1. Company Overview
  • 8.16.2. Company Snapshot
  • 8.16.3. Financial Overview
  • 8.16.4. Product Listing
  • 8.16.5. Entropy
• 8.17. Pharma Marine AS
  • 8.17.1. Company Overview
  • 8.17.2. Company Snapshot
  • 8.17.3. Financial Overview
  • 8.17.4. Product Listing
  • 8.17.5. Entropy
• 8.18. Clover Corporation
  • 8.18.1. Company Overview
  • 8.18.2. Company Snapshot
  • 8.18.3. Financial Overview
  • 8.18.4. Product Listing
  • 8.18.5. Entropy
• 8.19. Solutex
  • 8.19.1. Company Overview
  • 8.19.2. Company Snapshot
  • 8.19.3. Financial Overview
  • 8.19.4. Product Listing
  • 8.19.5. Entropy
• 8.20. Stepan Company
  • 8.20.1. Company Overview
  • 8.20.2. Company Snapshot
  • 8.20.3. Financial Overview
  • 8.20.4. Product Listing
  • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us